We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

In South-East Asia, an increasing number of people are lured into buying fake medicines, not knowing that these cheaper 'look alike' drugs often do not work. Investigations have shown that drug counterfeiting — the making of drugs that either have no active ingredients or have the wrong ones — is rising, but the number of deaths it causes is still largely unknown. 

Scientists and health officials are working to raise awareness among local doctors and patients about the problem. Experts hope to discuss possible solutions next week in Paris, France at the Second Global Forum on Pharmaceutical Anticounterfeiting.

In this article in Nature, Peter Aldhous says that the lack of official response, high costs of drug testing, shortage of qualified staff, unlicensed outlets and corruption are all factors that encourage drug counterfeiting. He adds that if the problem is to be tackled at its source, efforts should start in China where most of the drugs are made.

But there is hope. A 'minilab' project, for instance, involving a portable kit for drug testing, offers a cheap method of identifying counterfeits.

Link to full article in Nature 

Related topics